Pyridoxine/ja: Difference between revisions

Pyridoxine/ja
Created page with "<!-- Clinical data --> | pronounce = | tradename = | Drugs.com = {{Drugs.com|monograph|pyridoxine-hydrochloride}} | MedlinePlus = | licence_EU = <!-- EMA requires brand name --> | licence_US = <!-- FDA may use generic name --> | DailyMedID = Pyridoxine | pregnancy_AU = | pregnancy_AU_comment = Exempt | pregnancy_category= | dependency_liability = | addiction_liability = | routes_of_administration = By mouth, intrave..."
Created page with "<!-- Pharmacokinetic data --> | bioavailability = | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = 数週間(詳細は#代謝を参照のこと) | duration_of_action = | excretion ="
Line 49: Line 49:
| legal_status      = <!--For countries not listed above-->
| legal_status      = <!--For countries not listed above-->


<div lang="en" dir="ltr" class="mw-content-ltr">
<!-- Pharmacokinetic data -->
<!-- Pharmacokinetic data -->
| bioavailability  =
| bioavailability  =
Line 56: Line 55:
| metabolites      =
| metabolites      =
| onset            =
| onset            =
| elimination_half-life = several weeks (see [[#Metabolism]] for details)
| elimination_half-life = 数週間(詳細は[[#Metabolism/ja|#代謝]]を参照のこと)
| duration_of_action =
| duration_of_action =
| excretion        =
| excretion        =
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
<!-- Identifiers -->
<!-- Identifiers -->
| CAS_number        = 65-23-6
| CAS_number        = 65-23-6
Line 96: Line 93:
| specific_rotation =
| specific_rotation =
}}
}}
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
<div lang="en" dir="ltr" class="mw-content-ltr">